Skip to main content
ARS Home » Northeast Area » Beltsville, Maryland (BARC) » Beltsville Agricultural Research Center » Animal Biosciences & Biotechnology Laboratory » Research » Research Project #433526

Research Project: Evaluation of Oral Recombinant Vaccines Against Avian Coccidiosis

Location: Animal Biosciences & Biotechnology Laboratory

Project Number: 8042-32000-107-30-T
Project Type: Trust Fund Cooperative Agreement

Start Date: Oct 1, 2017
End Date: Dec 30, 2019

Objective:
Investigate effects of commercial Seppic oral adjuvants on recombinant protein vaccination against avian coccidiosis. Underling protective mechanisms that are associated with recombinant vaccination with oral adjuvants will be investigated.

Approach:
ARS will test vaccine efficacy of recombinant coccidian proteins that ARS produced with commercially available Seppic adjuvants using ARS-established in vivo coccidiosis disease challenge model. Challenge model will be evaluated using established clinical criteria for coccidiosis infection.